XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 14,088 $ 387,391
Short-term investments 93,386 99,715
Accounts receivable, net 307,201 301,775
Prepaid expenses 14,240 18,538
Income taxes receivable 21,529 14,249
Other current assets 8,857 18,896
Total current assets 459,301 840,564
Property and equipment, net 72,150 70,154
Goodwill 1,532,092 1,505,430
Intangible assets, net 20,965 21,565
Operating and finance lease right-of-use assets 67,504 65,461
Deferred income tax assets 93,218 88,344
Other assets 124,386 131,028
Total assets 2,369,616 2,722,546
Current liabilities:    
Accounts payable and accrued expenses 287,463 394,118
Current portion of long-term debt and finance lease liabilities 14,922 2,490
Current portion of operating lease liabilities 20,620 19,684
Income taxes payable 6,410 11,074
Total current liabilities 329,415 427,366
Line of credit 153,500 0
Long-term debt and finance lease liabilities, net 639,754 1,002,258
Long-term operating lease liabilities 42,047 41,396
Long-term professional liabilities 268,052 271,093
Deferred income tax liabilities 43,080 41,409
Other liabilities 48,338 42,332
Total liabilities 1,524,186 1,825,854
Commitments and contingencies
Shareholders' equity:    
Preferred stock; $.01 par value; 1,000 shares authorized; none issued 0 0
Common stock; $.01 par value; 200,000 shares authorized; 84,060 and 86,423 shares issued and outstanding, respectively 841 864
Additional paid-in capital 996,624 1,049,696
Accumulated other comprehensive income (2,585) 1,317
Retained deficit (149,450) (155,390)
Total Mednax, Inc. shareholders' equity 845,430 896,487
Noncontrolling interest 0 205
Total equity 845,430 896,692
Total liabilities and equity $ 2,369,616 $ 2,722,546